For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260401:nRSA1100Za&default-theme=true
RNS Number : 1100Z British American Tobacco PLC 01 April 2026
British American Tobacco p.l.c. ("the Company")
1 April 2026
Total Voting Rights and Issue of Shares
In accordance with PRM 1.6.4R, the Company (LEI: 213800FKA5MF17RJKT63)
confirms that between 17 March 2026 and 31 March 2026 it has issued and
allotted 604 ordinary shares of 25 pence each (ISIN GB0002875804) ("Shares")
in connection with the British American Tobacco p.l.c. Sharesave Scheme.
The Shares were admitted to trading on the London Stock Exchange Main Market
under the Company's existing block admission of shares for this purpose dated
1 May 2015 (the "Block Admission"). 70,511 ordinary shares (not yet in issue)
remain subject to the Block Admission.
The Shares rank equally and are fully fungible with the existing issued
ordinary shares of the Company.
Following this issuance of Shares, and in conformity with the Disclosure
Guidance and Transparency Rules provision 5.6.1, the Company confirms that as
at 31 March 2026, being the last trading day for that month, the Company's
issued share capital consisted of 2,172,840,264 Shares with voting rights (the
"Voting Rights Figure").
As at 31 March 2026, the Company held 132,669,859 Shares in Treasury.
The Voting Rights Figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their voting rights interest, or a change to that interest, in the Company
under the FCA's Disclosure Guidance and Transparency Rules.
Nancy Jiang
Senior Assistant Company Secretary
Enquiries:
Media Centre
press_office@bat.com | @BATplc
Investor Relations
Victoria Buxton | IR_team@bat.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVREAALFEFAKEFA
Copyright 2019 Regulatory News Service, all rights reserved